Frazier Life Sciences Acquisition Corp. II
Printed from CEF Radar (cefradar.com). Source: public filings at the U.S. Securities and Exchange Commission. Last checked: Nov 3, 2026, 4:44 a.m. New York time.
Frazier Life Sciences Acquisition Corp. II is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.
Is anyone targeting this fund?
Yes - 6 large investors hold stakes in this company, and 1 of them is pushing for changes.
- Frazier Life Sciences Holdings II LLC owns 20.5% and has said it may push for changes. Since Oct 21, 2026.
- Venrock Healthcare Capital Partners III, L.P. owns 9% as a passive investor. On file since Oct 27, 2026.
- RA Capital Management, L.P. owns 9% as a passive investor. On file since Oct 22, 2026.
- Deep Track Capital, LP owns 9% as a passive investor. On file since Oct 21, 2026.
- Coastlands Capital LP owns 6.4% as a passive investor. On file since Oct 16, 2026.
- Biotechnology Value Fund L P owns 6.4% as a passive investor. On file since Oct 21, 2026.
What this means for you
Frazier Life Sciences Holdings II LLC has told the regulator it may push for changes at this company. That usually means asking for a seat on the board, a sale of the company, or a change in how it is run.
Nothing is required of you now.
Large investors can also sell down and walk away. We show every notice they file, the day it is filed.
What happened, and when
-
Oct 27, 2026
Venrock Healthcare Capital Partners III, L.P. now owns 9%, as a passive investor.
Original document → -
Oct 22, 2026
RA Capital Management, L.P. now owns 9%, as a passive investor.
Original document → -
Oct 21, 2026
Frazier Life Sciences Holdings II LLC now owns 20.5%. It has said it may push for changes.
Original document → -
Oct 21, 2026
Biotechnology Value Fund L P now owns 6.4%, as a passive investor.
Original document → -
Oct 21, 2026
Deep Track Capital, LP now owns 9%, as a passive investor.
Original document →
Show all 6 events
-
Oct 16, 2026
Coastlands Capital LP now owns 6.4%, as a passive investor.
Original document →
Details: all notices, events and fund facts
| Date | Investor | Stake | Type of notice |
|---|---|---|---|
| Oct 27, 2026 | Venrock Healthcare Capital Partners III, L.P. | 9% | Passive investor |
| Oct 22, 2026 | RA Capital Management, L.P. | 9% | Passive investor |
| Oct 21, 2026 | Frazier Life Sciences Holdings II LLC | 20.5% | May push for changes |
| Oct 21, 2026 | Biotechnology Value Fund L P | 6.4% | Passive investor |
| Oct 21, 2026 | Deep Track Capital, LP | 9% | Passive investor |
| Oct 16, 2026 | Coastlands Capital LP | 6.4% | Passive investor |
No announcements from the fund on file. Most funds announce their payout on their own website, not in a filing with the regulator, so a cut or a raise there does not show up here.
- Run by
- not filed yet
- Fund family
- not filed yet
- Exchange
- not listed
See this fund's page at the SEC →
Email me when something new is filed for Frazier Life Sciences Acquisition Corp. II
Free. One email when a large investor files a notice, or when the fund announces a buy-back, a vote or a closing - usually within a day. No password. Most funds announce payout changes on their own website, where we do not look.